Cancer Survival

Source: us.rd.yahoo.com --- 5 days ago
HealthDay - SUNDAY, Oct. 5 (HealthDay News) -- Men who are overweight and who have high insulin levels when they are diagnosed with prostate Cancer may be more likely to die from the disease, research shows. ...

Source: news.yahoo.com --- 5 days ago
Reuters - Roche Holding AG and Genentech Inc said on Monday a study into the benefits of combining their Tarceva and Avastin drugs for lung Cancer patients did not show an increase in overall Survival. ...

Source: news.google.com --- 5 days ago
UPDATE 1-Roche says lung Cancer study did not boost Survival Reuters - 4 hours ago ZURICH, Oct 6 (Reuters) - Roche Holding AG (ROG.VX: Quote, Profile, Research, Stock Buzz) and Genentech Inc (DNA.N: Quote, Profile, Research, Stock Buzz) said on Monday a study into the benefits of combining two of their drugs for patients with lung ... Roche Cuts Price of Cancer Drug Wall Street Journal Two drugs don't boost lung Cancer Survival: Roche Reuters India Hays Pharma  - MSN Money  - WELT ONLINE  - RTT News all 26 news articles ...

Source: www.ncbi.nlm.nih.gov --- 5 days ago
Related Articles Surgical outcomes and Survival after multiorgan resection for locally advanced gastric Cancer. Am J Surg. 2008 Sep 25; Authors: Ozer I, Bostanci EB, Orug T, Ozogul YB, Ulas M, Ercan M, Kece C, Atalay F, Akoglu M BACKGROUND: Multiple organ resection for locally advanced (assumed T4) gastric Cancer is associated with high morbidity and mortality. Our aim was to evaluate the efficacy of these surgeries with regard to surgical morbidity, mortality, and Survival. METHODS: Fifty-six patients underwent potentially radical gastrectomy combined with invaded organ resection. Early and late results of multiorgan resection and clinicopathologic factors influencing these results were evaluated. RESULTS: Forty patients (71.4%) received 1 additional organ resection and 16 patients (28.6%) received 2 or more additional organ resections. Postoperative morbidity and mortality was 37.5% and 12.5%, respectively. Resection of 2 or more additional organs increased postoperative morbidity and advanced age increased mortality. The 1- and 3-year Survival rates were 53.3% and 28.1%, respectively. Advanced age, lymph node metastasis, and resection of more than 1 additional organ were significant prognostic factors for Survival. CONCLUSIONS: For patients with locally advanced gastric carcinoma, multiple organ resection is worthwhile with careful patient selection. PMID: 18823618 [PubMed - as supplied by publisher] ...

Source: www.ncbi.nlm.nih.gov --- 5 days ago
Related Articles [Efficacy, impact on Survival and cost of intensive follow-up after curative resection for colorectal Cancer aim] Ann Ital Chir. 2008 Jan-Feb;79(1):1-12 Authors: Cola B, Cuicchi D, Lecce F, Lombardi R, Ciaroni V, Dalla Via B AIM OF THE STUDY: This retrospective study was aimed at establishing the efficacy, impact on Survival and cost of an intensive follow-up program. METHODS: Data from 790 patients who underwent resections for primary colorectal carcinoma were prospectively entered into a data-base. Four hundred fifty-six patients who had radical surgery were followed-up with a 5-year preestablished schedule. Median follow-up was 42 months (range 2-108). RESULTS: Seventy-four adenomas, 7 metachronous carcinomas, 11 extra-colonic carcinomas and 96 recurrences (13 locoregional recurrences, 68 metastases and 15 cases of combined recurrences) were detected. Thirty-eight (39.6%) of 96 recurrences were amenable to salvage therapy and 23 relapses (24.0%) were radically resected. The median Survival of patients who had recurrences was 38 months. The 5-year overall Survival was significantly better in patients underwent radical surgery than those who were not treated with curative resection (60.0% vs 7.5%, p < 0.0001). Radical re-operations were performed in 2 (4.8%) of the 42 symptomatic patients and in 21 (38.9%) of the 54 cases with asymptomatic relapses. Median overall Survival of patients with asymptomatic recurrences wa ...

Source: www.moreover.com --- 5 days ago
By Emma Thomasson and Ben Hirschler ZURICH/LONDON (Reuters) - Roche Holding AG and Genentech Inc said on Monday a study into the benefits of combining their Tarceva and Avastin drugs for lung Cancer patients did not show an increase in overall ...

Source: www.ncbi.nlm.nih.gov --- 10 days ago
Related Articles Survival from testicular Cancer in England and Wales up to 2001. Br J Cancer. 2008 Sep 23;99 Suppl 1:S83-5 Authors: Huddart RA PMID: 18813271 [PubMed - in process] ...

Source: www.ncbi.nlm.nih.gov --- 10 days ago
Related Articles Survival from kidney Cancer in England and Wales up to 2001. Br J Cancer. 2008 Sep 23;99 Suppl 1:S96-7 Authors: Hancock BW PMID: 18813275 [PubMed - in process] ...

Source: www.ncbi.nlm.nih.gov --- 10 days ago
Related Articles Survival from bladder Cancer in England and Wales up to 2001. Br J Cancer. 2008 Sep 23;99 Suppl 1:S90-2 Authors: Whelan P PMID: 18813273 [PubMed - in process] ...

Source: sanfrancisco.bizjournals.com --- 5 days ago
Genentech Inc. and OSI Pharmaceuticals Inc. said a combination of the Cancer-fighting drugs Tarceva and Avastin does not show an overall increase in Survival rates for lung Cancer patients. (DNA) (OSIP) ...

Source: www.medscape.com --- 8 days ago
Commentary on a study on whether extended lymphadenectomy improves Survival in patients with gastric Cancer, published July 2008 in The New England Journal of Medicine. Medscape General Surgery ...

Source: www.medicinenet.com --- 4 days ago
Title: Obesity, Insulin Levels Impact Prostate Cancer Survival Category: Health News Created: 10/6/2008 2:00:00 AM Last Editorial Review: 10/6/2008 ...

Source: www.sciencedaily.com --- 8 days ago
A majority of women with breast Cancer today are candidates for lumpectomy, allowing for conservation of most of their breast tissue. Results of a new study, however, show that a number of women whose Cancer recurs in the same breast are treated with a second lumpectomy rather than a mastectomy, defying current treatment recommendations and cutting the number of years those women survive in half. ...

Source: www.medicalnewstoday.com --- 8 days ago
Data presented today at the 1st International Thoracic Oncology Congress Dresden (ITOCD) demonstrate that the addition of Erbitux® (cetuximab) to standard platinum-based chemotherapy in the 1st-line treatment of advanced NSCLC resulted in a significantly longer overall Survival. The patient population comprising all histological subtypes - and therefore closely resembled 'real world' clinical practice. ...

Source: www.medicalnewstoday.com --- 4 days ago
A new analysis finds considerable disparities in Survival related to race and socio-economic status among patients with head and neck Cancer. Published in the November 15, 2008 issue of Cancer, a peer-reviewed journal of the American Cancer Society, the study indicates that earlier diagnosis and greater access to treatment could improve outcomes for these cancers among African Americans and the poor. ...

Source: news.health.com --- 5 days ago
SUNDAY, Oct. 5 (HealthDay News) — Men who are overweight and who have high insulin levels when they are diagnosed with prostate Cancer may be more likely to die from the disease, research shows. This striking finding, published early online and expected to be in the November issue of The Lancet Oncology, is yet more reason [...] ...

Source: www.medpagetoday.com --- 10 days ago
NEW YORK (MedPage Today) -- Kidney Cancer patients who also have reduced renal function may be better off undergoing partial rather than radical nephrectomy, researchers here said. ...

Source: www.japantoday.com --- 8 days ago
A Health, Labor and Welfare Ministry research group announced on Friday five-year Survival rates for five types of Cancer based on statistics gathered from Japanese… ...

Source: www.medscape.com --- 5 days ago
A new analysis shows that race and socioeconomic status have a significant affect on patient Survival in head and neck Cancer, even after adjustment for other factors Medscape Medical News ...

Source: www.wiredprnews.com --- 4 days ago
Low insulin levels and low body mass numbers may improve prostate Cancer Survival rates, according to a recent study. Fort Worth, TX (WiredPRNews.com)—Having a low insulin levels and not being obese may be more important than chemotherapy, according to a recent study, when it comes to defeating prostate Cancer. According to an ... ...